Rkpd Pharmaceuticals & Trading Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2015
About Rkpd Pharmaceuticals & Trading
Rkpd Pharmaceuticals & Trading Private Limited (RPTPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2013 and has a history of 11 years and five months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Piyush Dwivedi, Awaniranjan Jagdishprasad, and Rajeev Pandey serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2013PTC059460
-
Company No.
059460
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2013
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Rkpd Pharmaceuticals & Trading?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Dwivedi
|
Director | 09-Sep-2013 | Current |
|
Awaniranjan Jagdishprasad
|
Director | 09-Sep-2013 | Current |
|
Rajeev Pandey
|
Director | 09-Sep-2013 | Current |
Financial Performance of Rkpd Pharmaceuticals & Trading.
Enhance accessibility to Rkpd Pharmaceuticals & Trading's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rkpd Pharmaceuticals & Trading?
Unlock access to Rkpd Pharmaceuticals & Trading's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Orbitol Intelligence Private LimitedAwaniranjan Jagdishprasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rkpd Pharmaceuticals & Trading?
Unlock and access historical data on people associated with Rkpd Pharmaceuticals & Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rkpd Pharmaceuticals & Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rkpd Pharmaceuticals & Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.